Takakusagi, Y., Sugyo, A., Tsuji, A. B., Sudo, H., Yasunaga, M., Matsumura, Y., . . . Higashi, T. (2022). The natural sulfoglycolipid derivative SQAP improves the therapeutic efficacy of tissue factor-targeted radioimmunotherapy in the stroma-rich pancreatic cancer model BxPC-3. Elsevier.
Cita Chicago Style (17a ed.)Takakusagi, Yoichi, Aya Sugyo, Atsushi B. Tsuji, Hitomi Sudo, Masahiro Yasunaga, Yasuhiro Matsumura, Fumio Sugawara, Kengo Sakaguchi, y Tatsuya Higashi. The Natural Sulfoglycolipid Derivative SQAP Improves the Therapeutic Efficacy of Tissue Factor-targeted Radioimmunotherapy in the Stroma-rich Pancreatic Cancer Model BxPC-3. Elsevier, 2022.
Cita MLA (8a ed.)Takakusagi, Yoichi, et al. The Natural Sulfoglycolipid Derivative SQAP Improves the Therapeutic Efficacy of Tissue Factor-targeted Radioimmunotherapy in the Stroma-rich Pancreatic Cancer Model BxPC-3. Elsevier, 2022.